Appropriateness of Using Patient-Derived Xenograft Models for Pharmacologic Evaluation of Novel Therapies for Esophageal/Gastro-Esophageal Junction Cancers

Lorin Dodbiba, Jennifer Teichman, Andrew Fleet, Henry Thai, Maud H. W. Starmans, Roya Navab, Zhuo Chen, Hala Girgis, Lawson Eng, Osvaldo Espin-Garcia, Xiaowei Shen, Bizhan Bandarchi, Joerg Schwock, Ming-Sound Tsao, Hala El-Zimaity, Sandy D. Der, Wei Xu, Robert G. Bristow, Gail E. Darling, Paul C. BoutrosLaurie E. Ailles, Geoffrey Liu*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Appropriateness of Using Patient-Derived Xenograft Models for Pharmacologic Evaluation of Novel Therapies for Esophageal/Gastro-Esophageal Junction Cancers'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry